In the pursuit of drug checking, our Near-Infrared (NIR) device stands as a beacon of hope, offering a comprehensive catalogue for the precise identification of narcotic substances. Aimed at supporting communities and health professionals, this state-of-the-art technology is a testament to our commitment to safety and well-being.
Substance detection:
Our NIR device provides a broad-spectrum detection capability, identifying substances from common narcotics to rare psychoactive elements, underpinning its versatility in various drug checking settings. The detailed list of detectable substances is meticulously curated and regularly updated, ensuring our partners have access to the most current data.
Prominent entries from our diverse catalogue showcase our NIR device’s versatility, ranging from well-known substances such as Cocaine and Heroin to more obscure ones like 2-FDCK and 3-CMC, reflecting the device’s capacity to adapt to various drug checking needs. We maintain a thorough and frequently updated list of identifiable substances, presented in detail to ensure our partners are informed with the most current knowledge.
Our handheld NIR device allows you to identify up to 3 substances in a mixture, including cutting agents (paracetamol, caffeine) and precursors. The portable spectrometer is capable of recognizing more than 150 substances, encompassing prominent illicit drugs such as cocaine, heroin, MDMA, methamphetamine, and ketamine. Additionally, it can detect new psychoactive substances (NPS), cutting agents, and precursors. This device facilitates the analysis of substances and mixtures in diverse forms, including powders, pills, liquids, or botanicals (e.g., cannabis).
Ease of use is a cornerstone of our device, with a user-friendly interface that simplifies complex analysis, delivering results swiftly and reliably. For those in need of immediate identification, our technology offers a quick response, which is critical in the fast-paced environment of drug checking.
Incorporation of the Full List (as of 12.05.2025)
Within our comprehensive index, you’ll notice certain substances distinguished by an asterisk (*). These marked items represent those that our current methodologies and technologies can quantify accurately. Substances marked with two asterisk (**) can only be identified in pure form.
Our constantly evolving database incorporates newly identified substances, ensuring immediate accessibility for all users.
For those requiring a more exhaustive list or specific details about our quantification processes, we invite you to connect with us. Our dedicated team is poised to offer the latest insights and support tailored to your unique requirements.
For further information or a more comprehensive list, please contact us here.
| Name | Category | Description |
| 1-(4-Methoxyphenyl) Piperazine di-HCl | Piperazine | 1-(4-Methoxyphenyl)piperazine (hydrochloride) is a piperazine derivative with stimulant-euphoric properties similar to amphetamine, acting on serotonin and dopamine systems. |
| 1-PEA | Phenethylamine | Endogenous 1-phenylethylamine with mild stimulant effects. |
| 1-Phenylethylamine | By-Products | Organic primary amine used in chiral resolutions; forms stable ammonium salts and imines. |
| 1-Phenylethylamine | Phenethylamine | Naturally occurring phenethylamine; mood-enhancing stimulant. |
| 1-Piperonylpiperazine | Piperazine | Designer-drug piperazine once found in street Ecstasy pills. |
| 14-DMT | Tryptamine | N,N-Dimethyltryptamine—naturally occurring psychedelic employed ritually as an entheogen. |
| 2-CMC | Cathinone | Synthetic stimulant (2-chloromethcathinone) of the cathinone class. |
| 2-FA | Phenethylamine | 2-Fluoroamphetamine research stimulant. |
| 2-FDCK | Arylcyclohexylamine | 2-Fluorodeschloroketamine, a dissociative anesthetic analogue of ketamine. |
| 2-Fluoromethamphetamine (2-FMA) | Phenethylamine | Fluorinated methamphetamine analog used as productivity aid. |
| 2-MMC | Cathinone | 2-Methylmethcathinone, a stimulant designer drug related to 3-MMC and 4-MMC. |
| 2-Oxo-PCE | Arylcyclohexylamine | Dissociative anesthetic analogue of O-PCE. |
| 2C-B | Phenethylamine | Synthetic psychedelic and entactogen with LSD-/MDMA-like effects. |
| 2C-B-FLY HCl | Phenethylamine | Bicyclic psychedelic phenethylamine (FLY series). |
| 2C-C | Phenethylamine | Psychedelic 2C family compound (20–40 mg oral). |
| 2C-E | Phenethylamine | Highly potent psychedelic phenethylamine. |
| 3-CMC | Cathinone | 3-Chloromethcathinone, a synthetic stimulant structurally akin to amphetamines. |
| 3-FEA | Phenethylamine | 3-Fluoroethamphetamine stimulant/empathogen. |
| 3-FPM HCl | Phenethylamine | 3-Fluorophenmetrazine stimulant sold online. |
| 3-HO-PCP | Arylcyclohexylamine | Hydroxy-PCP dissociative research chemical. |
| 3-MMA | Phenethylamine | 3-Methylmethamphetamine; stimulant with potential neuro- and cardio-toxicity. |
| 3-MMC | Cathinone | Empathogenic stimulant (3-methylmethcathinone) often sold as mephedrone substitute. |
| 3,4-DMMC | Cathinone | 3,4-Dimethylmethcathinone, a mephedrone analogue reported since 2010. |
| 3D-MXE | Arylcyclohexylamine | Deoxymethoxetamine dissociative designer drug. |
| 4-AcO-MET fumarate | Tryptamine | Acetoxy-tryptamine psychedelic (“metacetin”). |
| 4-Bromoamphetamine (4-BA) | Phenethylamine | Para-bromoamphetamine monoamine releaser; neurotoxic. |
| 4-CMC | Cathinone | Online-sold stimulant (4-chloromethcathinone) thought to release DA/5-HT. |
| 4-Fluoroamphetamine (4-FA) | Phenethylamine | Para-fluoroamphetamine producing stimulant-entactogenic effects. |
| 4-FMC | Cathinone | Flephedrone stimulant cathinone. |
| 4-FPP | Piperazine | Para-fluorophenylpiperazine mild psychoactive. |
| 4-HO-MALT | Tryptamine | 4-Hydroxy-N-methyl-N-allyltryptamine psychedelic. |
| 4-HO-McPT | Tryptamine | 4-Hydroxy-N-methyl-N-cyclopropyltryptamine psychedelic. |
| 4-HO-MET | Tryptamine | 4-Hydroxy-N-methyl-N-ethyltryptamine (“metocin”). |
| 4-HO-MiPT | Tryptamine | 4-Hydroxy-N-isopropyltryptamine psychedelic. |
| 4-MEC HCl | Cathinone | 4-Methyl-N-ethylcathinone hydrochloride—stimulant related to mephedrone. |
| 4-MePHP HCl | Cathinone | 4-Methoxy-α-pyrrolidinopentiophenone stimulant. |
| 4-Methylbuphedrone | Cathinone | 4-Me-buphedrone cathinone stimulant. |
| 4-MMC (mephedrone) | Cathinone | Widely abused cathinone with MDMA-like euphoria and high addiction potential. |
| 4-Pro-DMT | Tryptamine | Psychedelic tryptamine analogue of DMT. |
| 4Cl-PPP HCl | Cathinone | 4-Chloro-α-pyrrolidinopropiophenone stimulant. |
| 4F-Ketamine HCl | Arylcyclohexylamine | 4-Fluoroketamine dissociative anesthetic analog. |
| 4F-MPH | Other | 4-Fluoromethylphenidate dopamine reuptake inhibitor. |
| 4F-PVP HCl | Cathinone | 4′-Fluoro-α-pyrrolidinopentiophenone stimulant. |
| 5-MeO-DALT | Tryptamine | Psychedelic tryptamine synthesized by Shulgin. |
| 5-MeO-DiPT | Tryptamine | “Foxy” methoxy-tryptamine with hallucinogenic and empathogenic action. |
| 5-MeO-DMT freebase | Tryptamine | Powerful natural/animal psychedelic; “toad venom”. |
| 5Cl-AKB48 | Synthetic cannabinoid | 5-Chloro analog of AKB48 synthetic cannabinoid. |
| 5F-AB-PINACA | Synthetic cannabinoid | Potent CB-agonist linked to severe toxicity. |
| 5F-ADB | Synthetic cannabinoid | Potent indazole-carboxamide CB agonist linked to fatalities. |
| 5F-AMB | Synthetic cannabinoid | 5F-MMB-PINACA synthetic cannabinoid with strong CB1 activity. |
| 5F-APINACA | Synthetic cannabinoid | Also 5F-AKB48; strong CB1 agonist with unpredictable effects. |
| 5F-MDMB-PICA | Synthetic cannabinoid | Extremely potent synthetic cannabinoid common in seized “Spice”. |
| 5F-PB-22 | Synthetic cannabinoid | Synthetic cannabinoid associated with nausea, anxiety and seizures. |
| 6-APB | Phenethylamine | “Benzofury”; entactogen–stimulant resembling MDMA. |
| 6-MAM | Heroin | 6-Monoacetylmorphine, main active metabolite of heroin; marker of illicit use. |
| 9R-HHC | Cannabis | Hydrogenated THC isomer with cannabis-like effects. |
| 9S-HHC | Cannabis | Stereoisomer of HHC; non-naturally occurring cannabinoid. |
| AB-CHMINACA | Synthetic cannabinoid | Strong CB1/CB2 agonist found in “K2/Spice”, tied to intoxications. |
| AB-FUBINACA | Synthetic cannabinoid | Potent synthetic cannabinoid causing severe adverse effects. |
| AB-PINACA | Synthetic cannabinoid | CB-agonist implicated in organ damage and psychiatric symptoms. |
| Aceclofenac | Medicine | NSAID for pain and inflammation in arthritis. |
| Acetylcodeine | Opioids | Impurity in illicit heroin arising from residual codeine. |
| acides aminés | Other | Mixture of amino acids used as dietary supplement or inert filler. |
| Agomelatin Mepha 25 | Medicine | Agomelatine antidepressant acting on melatonin and 5-HT₂C receptors. |
| AKB-48 | Synthetic cannabinoid | APINACA; potent CB1/CB2 agonist. |
| Alpha-PhiP HCl | Cathinone | Synthetic cathinone stimulant with amphetamine-like effects. |
| Alpha-PHP | Cathinone | Recreational cathinone (“α-PVP cousin”) developed in 1960 s. |
| Alpha-PVP | Cathinone | Powerful stimulant (“flakka”) cathinone with high abuse potential. |
| Alprazolam | Benzodiazepine | Short-acting benzodiazepine (Xanax) for anxiety and panic. |
| AM-2201 | Synthetic cannabinoid | Potent CB1/CB2 agonist related to JWH-018. |
| AMB-FUBINACA | Synthetic cannabinoid | Indazole CB agonist linked to mass intoxications and deaths. |
| Amphetamine* | Phenethylamine | Central-nervous-system stimulant prescribed for ADHD and narcolepsy; strong abuse potential. |
| APAA | Precursor | α-Phenylacetoacetonitrile; regulated precursor for amphetamine synthesis. |
| APAAN | Precursor | α-Phenylacetoacetonitrile precursor for illicit amphetamine/meth. |
| Ascorbic acid | Cocaine cutting agent | Vitamin C added to aid solubility for injection. |
| Aspartame | Other | Low-calorie artificial sweetener (aspartic acid + phenylalanine). |
| Aspirin | Medicine | Acetylsalicylic acid—analgesic, antipyretic NSAID. |
| Avizafone | Benzodiazepine | Water-soluble pro-diazepam used as nerve-agent antidote. |
| Baking soda | Cocaine cutting agent | Sodium bicarbonate used to convert powder cocaine to crack. |
| Barbital Na (Veronal) | Barbiturate | Early long-acting barbiturate sedative–hypnotic. |
| Benzaldehyde | Other | Aromatic aldehyde; flavouring and chemical precursor. |
| Benzocaine | Cocaine HCl | Topical anesthetic commonly used to adulterate cocaine. |
| bk_2C-B | Phenethylamine | β-Keto analogue of 2C-B producing psychedelic effects. |
| BMDB HCl | Cathinone | 3,4-Methylenedioxy-N-benzylcathinone stimulant designer drug. |
| BMK Glycidate | Precursor | Glycidate ester precursor to BMK/P2P for meth-/MDMA-making. |
| Boric acid | Cocaine cutting agent | Antiseptic/insecticide occasionally found in drug adulterants. |
| Brewers yeast | Other | Saccharomyces cerevisiae; fungal source of B-vitamins, food/brewing additive. |
| Bromazolam | Benzodiazepine | Potent designer benzodiazepine first identified 2016. |
| Buphedrone HCl | Cathinone | Synthetic cathinone stimulant with mephedrone-like profile. |
| Buprenorphine | Medicine | Partial opioid agonist for pain and opioid-dependence therapy. |
| Butylone | Cathinone | Entactogenic stimulant (bk-MBDB) related to methylone. |
| Caffeine | Heroin cutting agent | Mild CNS stimulant often added to heroin. |
| Camazepam | Benzodiazepine | Anxiolytic benzodiazepine metabolised to temazepam. |
| Cannabicitran | Cannabis | Rare phytocannabinoid (CBTC) first isolated in 1974. |
| Cannabis Flower | Cannabis | Dried female “bud” rich in cannabinoids/terpenes. |
| Cannabis Leaf | Cannabis | Leaves of cannabis plant; lower cannabinoid content. |
| Cannabis oil CBD | Cannabis | CBD-dominant extract in carrier oil. |
| Cannabis Oil CBD (to be deleted) | Cannabis | CBD-dominant extract formulated in MCT or SBK carrier oils; flagged for removal in source list. |
| Cannabis oil THC* | Cannabis | THC-rich cannabis extract (“hash oil”) used orally or vaped. |
| Cannabis Oil THC (to be deleted) | Cannabis | Duplicate entry of THC-infused oils (MCT, SBK) marked for deletion. |
| Cannabis Pollen | Cannabis | Male-plant pollen used for breeding; dust rich in cannabinoids. |
| Cannabis Resin | Cannabis | Compressed trichomes (“hash”) high in THC. |
| CBC* | Cannabis | Cannabichromene phytocannabinoid; exhibits anti-inflammatory effects in vitro. |
| CBCA* | Cannabis | Cannabichromenic acid—precursor to CBC. |
| CBD* | Cannabis | Non-psychoactive cannabinoid with analgesic and anxiolytic potential. |
| CBD in CBD oil* | Cannabis | CBD content quantified in CBD-oil products. |
| CBD in extract CBD | Cannabis extract CBD | CBD present in concentrated CBD extracts. |
| CBD in Extract THC | Cannabis extract THC | CBD present as minor component in THC-rich extracts. |
| CBD in THC oil* | Cannabis | CBD measured as minor component in THC-oil. |
| CBD Isolate | Cannabis | Purified cannabidiol crystals from hemp. |
| CBDA* | Cannabis | Acidic precursor to CBD found in raw cannabis. |
| CBDV* | Cannabis | Non-psychoactive cannabidivarin studied for epilepsy. |
| CBDVA* | Cannabis | Acidic form of CBDV present in raw plant. |
| CBG* | Cannabis | “Mother cannabinoid” cannabigerol; non-psychoactive. |
| CBG in CBD oil* | Cannabis | CBG concentration determined in CBD-oil. |
| CBG in THC oil* | Cannabis | CBG level in THC-dominant oil. |
| CBG Isolate | Cannabis extract CBG | Purified cannabigerol with CB-receptor affinity. |
| CBGA* | Cannabis | Cannabigerolic acid—precursor to THC, CBD, CBC. |
| CBN* | Cannabis | Cannabinol from THC degradation; mildly sedative. |
| CBN crystals | Cannabis | Nearly pure cannabinol derived from aged cannabis. |
| Cellulose | Cutting Agents | Plant fibre used as inert bulking agent in tablets. |
| Citric acid | Cocaine cutting agent | Weak acid added to dissolve base drugs for injection. |
| Cocaine* | Cocaine | Powerful stimulant alkaloid from coca leaves; produces euphoria and carries high addiction/overdose risk. |
| Coffee | Other | Roasted Coffea seeds; caffeine source and odour masker. |
| Creatine | Cocaine HCl | Organic compound sometimes used to cut cocaine powder. |
| Cutting agents | Cutting Agents | Generic term for adulterants added to bulk illicit drugs. |
| D-Maltose monohydrate | Cocaine cutting agent | Disaccharide sugar occasionally used as bulking agent. |
| Delta-8 THC | Cannabis | Psychoactive THC isomer with milder effects than Δ9-THC. |
| Deschloroetizolam | Benzodiazepine | Designer benzodiazepine analog of etizolam. |
| Deschloroketamine (DXE) | Arylcyclohexylamine | Chlorine-free ketamine analogue; dissociative effects. |
| Dextromethorphan (DXM) | Medicine | OTC antitussive; dissociative at high doses. |
| Diazepam | Benzodiazepine | Long-acting benzodiazepine for anxiety, seizures, muscle spasms. |
| Diltiazem | Medicine | Calcium-channel blocker for hypertension and angina. |
| Dimethocaine (DMC) | Cocaine | Local-anesthetic stimulant similar to cocaine but weaker. |
| Dimethyl sulfone | Methamphetamine cutting agent | MSM dietary supplement often used to adulterate methamphetamine. |
| Dipentylone | Cathinone | Synthetic cathinone stimulant found in “bath salt” products. |
| Diphenhydramine (DPH) | Medicine | First-gen antihistamine with strong sedative properties. |
| DMT | Tryptamine | Powerful natural psychedelic widespread in plants and animals. |
| DMXE | Arylcyclohexylamine | Deoxymethoxetamine dissociative research chemical. |
| Dogmatil 200 | Medicine | Sulpiride antipsychotic capsule 200 mg. |
| Dominal 40 | Medicine | Promethazine antihistamine/sedative tablet 40 mg. |
| Dormicum | Medicine | Midazolam sleeping pill (short-acting benzodiazepine). |
| Doxephin neuraxpharm 50 | Medicine | Doxepin tricyclic antidepressant 50 mg capsule. |
| Duloxetin Mepha 60 | Medicine | Duloxetine SNRI antidepressant 60 mg. |
| Ephedrine | Medicine | Sympathomimetic stimulant and key meth precursor. |
| Ephylone | Cathinone | N-Ethylpentylone stimulant common in 2016–19 seizures. |
| EPT | Tryptamine | N-Ethyl-N-propyltryptamine rare psychedelic. |
| Escitalopram Mepha 20 | Medicine | Escitalopram SSRI tablet 20 mg. |
| Ethanol | Cutting Agents | Common alcohol used as solvent/diluent in drug prep. |
| Ethylone | Cathinone | Entactogenic stimulant (bk-MDEA) similar to methylone. |
| Eutylone | Cathinone | β-Keto analogue of butylone; stimulant/empathogen. |
| Extract CBD | Cannabis extract CBD | Generic term for cannabinoid-rich CBD extracts. |
| Extract THC | Cannabis extract THC | Generic term for THC-dominant extracts (hash oil, etc.). |
| Fentanyl** | Opioids | Opioid 50–100 × stronger than morphine; high overdose risk. |
| Flour* | Other | Finely-milled grain powder filler. |
| Flubromazepam | Benzodiazepine | Long-acting designer benzodiazepine. |
| Flunitrazolam | Benzodiazepine | Potent hypnotic triazolobenzodiazepine related to flunitrazepam. |
| Fluoxetin Mepha Dispersible 20 | Medicine | Fluoxetine dispersible SSRI 20 mg. |
| formetorex | Phenethylamine | Amphetamine-like anorectic stimulant (limited current use). |
| Frankincense | Other | Aromatic Boswellia resin; incense or inert filler. |
| Fructose | Cutting Agents | Fruit sugar sometimes used as inert filler in powders. |
| Gabapentin | Cutting Agents | Anticonvulsant occasionally misused or used as adulterant. |
| GBL (gamma-butyrolactone) | Other | Industrial solvent and pro-drug of GHB with CNS depressant effects. |
| GHB | Other | CNS depressant used medically for narcolepsy and recreationally for euphoria. |
| Gluconic Acid | Other | Mild organic acid from glucose; chelating agent in pharma/food. |
| Glucose | Cocaine HCl | Common sugar bulking agent in cocaine powders. |
| glutamate | Other | Glutamic acid; neurotransmitter and flavour enhancer (MSG). |
| Glutamine | Cocaine HCl | Amino acid sometimes present as filler. |
| glycerine | Other | Viscous polyol solvent/humectant; e-liquid base. |
| Griseofulvin | Heroin cutting agent | Antifungal drug occasionally found cutting heroin. |
| Heroin* | Heroin | Diacetylmorphine opioid causing intense euphoria and severe dependence; illicit street drug. |
| HHC | Cannabis | Hydrogenated THC analogue with intoxicating effects. |
| Hydrocodone | Opioids | Semi-synthetic opioid analgesic often combined with acetaminophen. |
| Hydroxyzine | Cocaine HCl | Antihistamine sometimes encountered as adulterant. |
| Ibuprofen | Medicine | OTC NSAID for pain, fever, inflammation. |
| Imovane 7,5 | Medicine | Zopiclone hypnotic tablet 7.5 mg. |
| Inositol | Cocaine HCl | Sugar alcohol frequently used as benign cocaine adulterant. |
| Isopropylphenidate | Medicine | Piperidine stimulant research chemical related to methylphenidate. |
| JWH-018 | Synthetic cannabinoid | Early full CB1/CB2 agonist in “Spice” products. |
| JWH-019 | Synthetic cannabinoid | Naphthoylindole cannabinoid agonist. |
| JWH-073 | Synthetic cannabinoid | Partial CB agonist more potent than THC. |
| JWH-081 | Synthetic cannabinoid | Potent naphthoylindole synthetic cannabinoid. |
| JWH-122 | Synthetic cannabinoid | Methyl analogue of JWH-018 with nanomolar CB1 affinity. |
| JWH-200 | Synthetic cannabinoid | Aminoalkylindole CB agonist with analgesic properties. |
| JWH-203 | Synthetic cannabinoid | Phenylacetylindole CB agonist (Ki ≈ 8 nM). |
| JWH-210 | Synthetic cannabinoid | Potent naphthoylindole CB agonist (Ki < 1 nM). |
| JWH-250 | Synthetic cannabinoid | Phenylacetylindole CB1/CB2 agonist. |
| Ketamine* | Arylcyclohexylamine | Dissociative anesthetic inducing trance-like analgesia and amnesia; used medically and recreationally. |
| Ketamine hydroxylimine | Precursor | Intermediate step in industrial ketamine synthesis. |
| L-leucine | Other | Essential branched-chain amino acid supplement. |
| L-valine | Other | Essential branched-chain amino acid supplement. |
| Lactose | Cocaine HCl | Milk sugar—common inert bulking agent. |
| Lamotrigine Sandoz 50 | Medicine | Lamotrigine anticonvulsant/ mood stabiliser 50 mg. |
| Levamisole* | Cocaine HCl | Anthelmintic frequently cutting cocaine; causes agranulocytosis. |
| Levetiracetam Desitin 500 | Medicine | Levetiracetam antiepileptic tablet 500 mg. |
| Lidocaine | Cocaine cutting agent | Local anesthetic that mimics cocaine’s numbing effect. |
| Likely Heroin HCl (low purity) | Heroin | Low-purity heroin hydrochloride sample. |
| LSD | Tryptamine | Lysergic acid diethylamide—potent classic psychedelic. |
| MAM-2201 | Synthetic cannabinoid | Potent indole-based synthetic cannabinoid. |
| Mannitol | Cocaine HCl | Sugar alcohol often used as inert cut in cocaine. |
| MAPA | Precursor | N-Methyl-1-phenyl-2-propanamine precursor for meth. |
| MCT Cannabis oil | Cannabis | Medium-chain triglyceride carrier oil infused with cannabinoids. |
| MDA | Phenethylamine | Entactogenic/psychedelic amphetamine analogue related to MDMA. |
| MDMA* | Phenethylamine | Empathogenic stimulant (“ecstasy”) that heightens mood, empathy and energy. |
| MDMB-4en-PINACA | Synthetic cannabinoid | Indazole synthetic cannabinoid prevalent in seizures. |
| MDMB-CHMICA | Synthetic cannabinoid | Potent synthetic cannabinoid linked to mass poisonings. |
| MDMB-INACA | Synthetic cannabinoid | Precursor that yields multiple potent synthetic cannabinoids. |
| MDP2P | Precursor | 3,4-MDP-2-propanone key precursor for MDMA. |
| MDPHP | Cathinone | Stimulant “monkey dust” reported in Europe. |
| MDPPP | Phenethylamine | 3,4-MD α-pyrrolidinopropiophenone stimulant. |
| Medicine | Medicine | Generic category entry for assorted pharmaceutical tablets. |
| Menthol | Other | Cooling monoterpene from mint oil; tobacco/ topical additive. |
| MePPP | Phenethylamine | 4-Methyl-α-pyrrolidinopropiophenone stimulant. |
| Mescaline HCl | Phenethylamine | Naturally occurring psychedelic from cacti. |
| Mescaline Sulfate | Phenethylamine | Sulfate salt of classic psychedelic mescaline. |
| Metamizole | Medicine | Non-opioid analgesic/antipyretic (dipyrone). |
| Methallylescaline | Phenethylamine | Psychedelic mescaline analogue with allyl group. |
| Methamphetamine* | Phenethylamine | Extremely potent stimulant (“crystal meth”) with long duration, neurotoxicity and strong addiction liability. |
| Methanol | Cutting Agents | Toxic alcohol sometimes present as solvent contaminant. |
| Methylone | Cathinone | Entactogenic stimulant (bk-MDMA) similar to MDMA. |
| Methylphenidate | Medicine | CNS stimulant (Ritalin) for ADHD. |
| MMDPPA | Phenethylamine | Synthetic phenethylamine with limited data. |
| Morphine | Opioids | Natural opioid analgesic from opium poppy. |
| MSG | Other | Monosodium glutamate flavour enhancer, inert filler. |
| MXiPr | Arylcyclohexylamine | Isopropoxy-substituted dissociative related to MXE. |
| MXPr | Arylcyclohexylamine | Methoxypropamine NMDA-antagonist dissociative. |
| N-Alpha-Dimethylbenzylamine | Other | Amine sometimes encountered as impurity. |
| N-Cyclohexylmethylone | Cathinone | Cathinone stimulant first identified 2022. |
| N-Desethyletonitazene | Opioids | Extremely potent benzimidazole opioid metabolite. |
| N-Ethylcathinone HCl | Cathinone | Ethcathinone stimulant; pro-drug releasing cathinone. |
| N-ethylnorpentedrone | Cathinone | N-Ethyl analog of norpentedrone stimulant. |
| N-Ethylpentedrone HCl | Cathinone | N-Ethylpentedrone cathinone stimulant. |
| N-Ethylpentylone HCl | Cathinone | N-Ethylpentylone empathogenic stimulant. |
| n-formyl-n-metyl-3,4-methylenedioxyamphetamine | Phenethylamine | Formylated MDMA analogue (“Foxy”) psychedelic. |
| N-Isopropylbenzylamine | Phenethylamine | Inert methamphetamine look-alike used as substitute. |
| nandrolone | Other | Anabolic-androgenic steroid used medically and illicitly. |
| Naproxen Mepha 500 | Medicine | Naproxen NSAID tablet 500 mg. |
| Nicotine | Other | Addictive alkaloid stimulant from tobacco. |
| Norflurazepam | Benzodiazepine | Long-acting metabolite/designer benzodiazepine. |
| Noscapine* | Heroin | Opium-alkaloid cough suppressant seen in heroin samples. |
| Oxycodone | Medicine | Semi-synthetic opioid for moderate-severe pain. |
| P2NP | Precursor | Phenyl-2-nitropropene precursor used in clandestine amphetamine synthesis. |
| palmitic acid | MDMA cutting agent | Fatty acid tablet excipient sometimes used to cut MDMA tablets. |
| Papaverine | Heroin | Opium alkaloid and vasodilator occasionally present in heroin. |
| Paracetamol* | Medicine | Acetaminophen analgesic/antipyretic often in street pills. |
| PB-22 | Synthetic cannabinoid | Indole synthetic cannabinoid potent CB1 agonist in “Spice”. |
| Pentedrone HCl | Cathinone | Stimulant cathinone (“bath salt”) first found in 2010. |
| Pentobarbital | Barbiturate | Short-acting barbiturate sedative–euthanasia agent. |
| Pentylone | Cathinone | Synthetic cathinone stimulant raising DA, 5-HT and NE. |
| Pepper | Other | Common culinary pepper spice. |
| Phenacetin* | Cocaine HCl | Banned analgesic still found adulterating cocaine. |
| Phenazepam | Benzodiazepine | Long-acting Soviet-developed anxiolytic/hypnotic. |
| Phenethylamine | Phenethylamine | Endogenous trace amine; backbone for many stimulants. |
| Phenylpropanolamine HCl | Other | Sympathomimetic decongestant withdrawn for stroke risk; meth precursor. |
| PMK Glycidate | Precursor | Key MDMA precursor (3,4-MDP2P glycidate). |
| PMMA | Polymers | Polymethyl methacrylate plastic material. |
| Pregabalin | Medicine | Anticonvulsant-analgesic (Lyrica) with abuse potential. |
| Procaine | Cocaine HCl | Local anesthetic used to adulterate cocaine. |
| Propylene glycol | Other | Hygroscopic solvent; GRAS; e-liquid carrier. |
| Pseudococaine | Cocaine | Cocaine structural analogue used as reference or substitute. |
| Pseudoephedrine | Precursor | OTC decongestant diverted as meth precursor. |
| R-epinephrine (Adrenaline) | Medicine | Epinephrine for anaphylaxis, asthma, cardiac arrest. |
| Ramipril Mepha 10 | Medicine | Ramipril ACE-inhibitor tablet 10 mg. |
| RCS-4 | Synthetic cannabinoid | SR-19 indole cannabinoid agonist in herbal incense. |
| Salicylic acid | Other | Beta-hydroxy acid used in acne treatment and aspirin precursor. |
| SBKO Cannabis oil | Cannabis | Cannabis extract formulated in SBK carrier oil. |
| Sertralin Mepha 100 | Medicine | Sertraline SSRI tablet 100 mg. |
| Sniffy | Other | Legal stimulant sniff powder (caffeine + vitamins). |
| Sodium Fluoride | Other | Water-fluoridation salt and pesticide. |
| Sodium Hydroxide | Other | Caustic-soda industrial base reagent. |
| Sorbitol | Cocaine HCl | Sugar-alcohol bulking agent in cocaine powders. |
| stearic acid | MDMA cutting agent | Fatty-acid excipient in pressed tablets. |
| Strychnine | Other | Highly toxic alkaloid; historical pesticide, convulsant. |
| STS-135 | Synthetic cannabinoid | Naphthoylindole CB agonist (“XLR-11 analog”). |
| Sucrose* | Cocaine cutting agent | Table-sugar filler in illicit powders. |
| Talc | Other | Hydrated magnesium-silicate filler. |
| Taurine | Other | Organic acid common in energy drinks. |
| Tégrétol 400 | Medicine | Carbamazepine anticonvulsant tablet 400 mg. |
| Tetracaine | Cocaine cutting agent | Potent topical anesthetic mimicking cocaine’s numbing effect. |
| Tetrahydroharman | Other | β-Carboline alkaloid with psychoactive potential. |
| Tetrahydroharmine | Other | β-Carboline from ayahuasca vine; MAO-A inhibitor. |
| THC* | Cannabis | Primary psychoactive compound in cannabis. |
| THC in CBD oil* | Cannabis | Trace THC present in CBD-oil products. |
| THC in extract CBD | Cannabis extract CBD | Residual THC measured in CBD extracts. |
| THC in Extract THC | Cannabis extract THC | Principal psychoactive cannabinoid in THC-rich extracts. |
| THC in THC oil* | Cannabis | THC concentration in THC-rich oil. |
| THCA* | Cannabis | Non-psychoactive acidic precursor to THC. |
| THCA | Cannabis | Tetrahydrocannabinolic acid—non-psychoactive precursor that decarboxylates to THC when heated. |
| THCV | Cannabis | Tetrahydrocannabivarin with appetite-suppressant potential. |
| THCVA* | Cannabis | Acidic precursor to THCV. |
| Thiamin HCl | Other | Vitamin B1 nutritional supplement. |
| toluic acid | Other | Methylbenzoic acid isomer in dyes and perfume synthesis. |
| Total CBC* | Cannabis | Total cannabichromene content measurement. |
| Total CBDV* | Cannabis Hybride | Total cannabidivarin content in hybrid cannabis. |
| total CBG* | Cannabis CBG | Total cannabigerol measurement. |
| Tramadol* | Medicine | Synthetic opioid analgesic for moderate pain; dual μ-opioid agonist and SNRI mechanism. |
| Tusi | Ketamine | Street “pink cocaine” mix (ketamine + MDMA ± others). |
| Tyrosine | Other | Non-essential amino acid precursor to catecholamines. |
| UR-144 | Synthetic cannabinoid | Abbott-origin indole cannabinoid agonist. |
| Valproate Chrono Sanofi 300 | Medicine | Valproic acid extended-release tablet 300 mg. |
| Vegetable hemp oil | Cannabis | Nutrient oil pressed from hemp seeds. |
| Washed Cannabis Flower | Cannabis | Bud washed to remove contaminants/solvents. |
| Water* | Cannabis | Residual moisture content in cannabis product. |
| Water Activity* | Cannabis CBD | aw value indicating microbial stability. |
| Wax THC | Cannabis extract THC | Highly concentrated butane hash-oil “wax”. |
| Wildkraut | Other | “Energy-sniff” legal powder. |
| x-CMC | Cathinone | Synthetic cathinone stimulant with unspecified ring-substitution (“x” denotes variable isomer); sold as a legal-high powder. |
| XLR-11 | Synthetic cannabinoid | Synthetic cannabinoid linked to kidney-injury outbreaks. |
| Xylazine | Other | Veterinary sedative; emerging drug adulterant. |
Beyond narcotics, we offer precision analysis for polymers and cannabis. Stakeholders needing advanced identification for these substances can access our detailed and frequently updated compilations.
Access the Polymer Solutions List here, the Cannabis Solutions List here and the Law Enforcement list here; discover the versatility and precision that our technology offers.
Conclusion
In this era of conscientious drug checking, our Near-Infrared (NIR) technology emerges as a crucial resource. By offering a precise and comprehensive catalogue for narcotic substance identification, we empower community support systems and health professionals with an essential tool for safety and care. Our technology’s seamless interface and rapid detection capabilities reflect our devotion to innovation in service of society’s well-being. As we advance, we remain dedicated to updating and expanding our substance listings, ensuring that those on the front lines of drug checking have the accurate information they need at the speed they require. With our extensive resources for polymers and cannabis analysis included, we reaffirm our commitment to advancing drug checking with unwavering precision and reliability.
To delve further into the world of spectroscopy and discover the full capabilities of NIRLAB’s technology, we invite you to explore our other insightful articles, here. For personalized inquiries, reach out to us at contact@nirlab.com.
NIRLAB // Just Truth
